. 2014 Aug 4;9(8):e104098. doi: 10.1371/journal.pone.0104098

Table 1. Genotype frequencies.

Doxycycline treatment	Background strain	Obtained genotype frequencies (%)
		sm22α-rtTA⁺; tetop-LA^G608G−	sm22α-rtTA⁻; tetop-LA^G608G+	sm22α-rtTA⁺; tetop-LA^G608G+	sm22α-rtTA⁻; tetop-LA^G608G−
D0	C57BL/6J	30.2	26.4	34.0	9.4
	C57BL/6J; FVB/NCrl	14.6	29.2	33.3	22.9
E0	C57BL/6J	36.7	24.1	17.7	21.5
	C57BL/6J; FVB/NCrl	22.9	40.0	17.1	20.0

D0, mice supplied with doxycycline from the date of birth; E0, mice supplied with doxycycline during embryogenesis and postnatally; +, presence of transgene; −, absence of transgene. The expected frequency for each individual genotype was 25%.